Market Tracker

03/22 5:16pm ET

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.5254
Delayed Data
As of 3:59pm ET
 -0.0269 / -4.87%
Today’s Change
0.39
Today|||52-Week Range
2.64
-23.83%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.55
Today’s open0.56
Day’s range0.53 - 0.57
Volume88,426
Average volume (3 months)203,549
Market cap$14.4M
Dividend yield--
Data as of 3:59pm ET, 03/22/2017

Growth & Valuation

Earnings growth (last year)+33.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)-32.49%
P/E ratioNM
Price/Sales142.93
Price/Book0.56

Competitors

 Today’s
change
Today’s
% change
DPRXDipexium Pharmaceuti...0.000.00%
EVARLombard Medical Inc-0.01-1.45%
CYCCCyclacel Pharmaceuti...-0.19-5.34%
OGXIOncoGenex Pharmaceut...-0.02-3.77%
Data as of 3:59pm ET, 03/22/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$133.0K
Annual profit (last year)-$15.2M
Net profit margin-11,451.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Secretary
Thomas Kenwood Equels
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts